BioVie Inc. (BIVI) vs Kiora Pharmaceuticals, Inc. (KPRX)
A side-by-side comparison of BioVie Inc. and Kiora Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIVI
BioVie Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 10:43 AM EDT
KPRX
Kiora Pharmaceuticals, Inc.
$2.54HealthcareDelayed quote: Oct 6, 2026, 10:41 AM EDT
Total return — BIVI vs KPRX
growth of $100 · dividends reinvested · last 10yBIVI -100.0% (-54.2%/yr)KPRX -100.0% (-56.0%/yr)BIVI compounded faster over this window
BIVI KPRX
BIVI vs KPRX: by the numbers
- •KPRX is the larger company ($11M vs $11M market cap).
Metrics side by side
Valuation
| Metric | BIVI | KPRX |
|---|---|---|
| P/B ratio | 1.07 | 0.67 |
Profitability
| Metric | BIVI | KPRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -214.92% | -65.18% |
| ROIC | -216.67% | -59.42% |
Growth (annualized)
| Metric | BIVI | KPRX |
|---|---|---|
| Total return CAGR (5Y) | -70.37% | -67.06% |
Frequently asked
- How have BIVI and KPRX total returns compared?
- Over the past 10 years, BIVI delivered -54.09% and KPRX delivered -55.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.